TD Asset Management’s Cytokinetics CYTK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18M | Buy |
544,292
+97,464
| +22% | +$3.22M | 0.02% | 512 |
|
|
2025
Q1 | $18M | Sell |
446,828
-77,806
| -15% | -$3.13M | 0.02% | 518 |
|
|
2024
Q4 | $24.7M | Sell |
524,634
-36,384
| -6% | -$1.71M | 0.02% | 474 |
|
|
2024
Q3 | $29.4M | Buy |
561,018
+200,420
| +56% | +$10.5M | 0.03% | 411 |
|
|
2024
Q2 | $19.5M | Buy |
360,598
+76,078
| +27% | +$4.12M | 0.02% | 499 |
|
|
2024
Q1 | $19.9M | Buy |
284,520
+102,480
| +56% | +$7.18M | 0.02% | 488 |
|
|
2023
Q4 | $15.2M | Buy |
182,040
+82,400
| +83% | +$6.88M | 0.01% | 530 |
|
|
2023
Q3 | $2.94M | Buy |
99,640
+26,297
| +36% | +$775K | ﹤0.01% | 853 |
|
|
2023
Q2 | $2.39M | Sell |
73,343
-600
| -0.8% | -$19.6K | ﹤0.01% | 923 |
|
|
2023
Q1 | $2.6M | Buy |
73,943
+22,800
| +45% | +$802K | ﹤0.01% | 905 |
|
|
2022
Q4 | $2.34M | Buy |
51,143
+12,600
| +33% | +$577K | ﹤0.01% | 940 |
|
|
2022
Q3 | $1.89M | Buy |
38,543
+8,600
| +29% | +$421K | ﹤0.01% | 1019 |
|
|
2022
Q2 | $1.18M | Sell |
29,943
-557
| -2% | -$21.9K | ﹤0.01% | 1150 |
|
|
2022
Q1 | $1.12M | Buy |
30,500
+22,100
| +263% | +$814K | ﹤0.01% | 1211 |
|
|
2021
Q4 | $383K | Buy |
+8,400
| New | +$383K | ﹤0.01% | 1409 |
|
|
2020
Q4 | – | Sell |
-35,700
| Closed | -$773K | – | 1445 |
|
|
2020
Q3 | $773K | Buy |
+35,700
| New | +$773K | ﹤0.01% | 1135 |
|
|
2018
Q1 | – | Sell |
-18,300
| Closed | -$149K | – | 1347 |
|
|
2017
Q4 | $149K | Hold |
18,300
| – | – | ﹤0.01% | 1313 |
|
|
2017
Q3 | $265K | Buy |
+18,300
| New | +$265K | ﹤0.01% | 1254 |
|
|
2013
Q4 | – | Sell |
-18,868
| Closed | -$143K | – | 1296 |
|
|
2013
Q3 | $143K | Buy |
+18,868
| New | +$143K | ﹤0.01% | 1228 |
|